Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
General Catalyst

General Catalyst

A venture capital firm that invests in early state start ups in education, research, health care, and social work.

General Catalyst is a venture capital firm founded in 2000. It was established by Bill Fitzgerald, David Fialkow, David Orfao, and Joel Cutler. General Catalyst is headquartered in Cambridge, Massachusetts with additional offices in New York City, San Francisco, and Palo Alto. As of October 2019, the firm has sold off its shares in 193 companies and is currently managing a portfolio of 226 companies.

Timeline

March 31, 2020
General Catalyst announces that it has secured $2.3 billion in capital commitments across three funds: a $600 million early-stage fund, a $1 billion growth fund for companies with $10 million-plus in annual revenue, and a $700 million "endurance fund" to back large companies doing more than $100 million in sales.
2000
General Catalyst was founded by Bill Fitzgerald, David Fialkow, David Orfao and Joel Cutler.

Invested in

Associated investment funds

Patents

Funding Rounds Participated In

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

News

Title
Author
Date
Publisher
Description
Heather Landi
October 8, 2021
FierceHealthcare
Online pediatric behavioral health startup Elemy launched a little more than a year ago and has now vaulted to unicorn status after raising $219 million in a series B funding round. The company, formerly known as Sprout Therapy, is now valued at $1.15 billion
Heather Landi
September 8, 2021
FierceHealthcare
Equum Medical pulled in $20 million to build out acute care telehealth, Oprah Winfrey backs Maven Clinic's $110 million round, a startup that developed a voice vital sign to quantify depression banked $26 million and other funding news in August.
Christine Hall
September 1, 2021
TechCrunch
The free itinerary maker and road trip planner takes the best parts of Google Docs and Maps and enables users to import the information and map out their trips with others.
Heather Landi
August 3, 2021
FierceHealthcare
Olive pulled in $400 million to build out its enterprise AI for hospitals, Arianna Huffington's Thrive Global banked $80 million, a digital clinic for treating multiple addictions nabbed $64 million and other funding news in July.
Kyle LaHucik
July 29, 2021
FierceBiotech
Ten months after securing its first drug approval for head and neck cancer in Japan, Rakuten Medical has picked up another megaround of financing, in the form of a $166 million series D, to expand into new therapies and indications. The San Mateo, California-based company said Thursday the series D translates to $75 million in new capital and $91 million converted promissory notes.
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.